在重症监护病房实施抗菌药物管理计划和全面筛查与患者总体临床结果的关系。

Jelena Micik, Aleksandar Dimovski, Zoran Sterjev, Ljubica Shuturkova, Aleksandra Grozdanova
{"title":"在重症监护病房实施抗菌药物管理计划和全面筛查与患者总体临床结果的关系。","authors":"Jelena Micik, Aleksandar Dimovski, Zoran Sterjev, Ljubica Shuturkova, Aleksandra Grozdanova","doi":"10.2478/prilozi-2024-0019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The high prevalence of resistant microorganisms indicates a multidisciplinary approach, which will ensure efficiency and balance between resistance therapy of choice and the implementation of an antimicrobial stewardship (AMS) program in intensive unit care (ICU).</p><p><strong>Objectives: </strong>The objectives are based on the assessment of AMS in a cardiac surgical intensive care unit (CICU), by determination with the reduction of: inotropic support, length of antibiotic treatment, and need for renal replacement therapy (RRT).</p><p><strong>Material and methods: </strong>The research is a retrospective, group comparative, analytical cross-sectional study, in the period from 2020-2023, within the Cardiosurgery department, at Acibadem Sistina. 1277 patients participated in the research, divided into two groups: group 1 (2020-2021) and group 2 (2022-2023). Primary endpoints investigated: inotropic support, need for RRT and length of antibiotic treatment. Secondary endpoints investigated: optimization of antibiotic therapeutic regimen and clinical outcome assessment of patients (survival).</p><p><strong>Results: </strong>The inotropic support during 24, 48 and 72 h was statistically significantly lower in group 2. A statistically significant shorter length of time for antibiotic treatment was determined in patients in group 2 (p=0.000), as well as a lower value of the need for RRT. A statistically significant difference in time to event (fatal outcome) was determined between the two groups (p=0.000). A significant difference (p=0.000) was determined in the prescription and optimization of the therapeutic regimen.</p><p><strong>Conclusion: </strong>Integrating AMS, initial comprehensive microbiological screening and application of biomarkers in the CICU, established appropriately, will result in improved overall clinical outcome for patients.</p>","PeriodicalId":74492,"journal":{"name":"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)","volume":"45 3","pages":"13-24"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Implementing an Antimicrobial Stewardship Program and Complete Screening in an Intensive Care Unit in Relation to the Overall Clinical Outcome of Patients.\",\"authors\":\"Jelena Micik, Aleksandar Dimovski, Zoran Sterjev, Ljubica Shuturkova, Aleksandra Grozdanova\",\"doi\":\"10.2478/prilozi-2024-0019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The high prevalence of resistant microorganisms indicates a multidisciplinary approach, which will ensure efficiency and balance between resistance therapy of choice and the implementation of an antimicrobial stewardship (AMS) program in intensive unit care (ICU).</p><p><strong>Objectives: </strong>The objectives are based on the assessment of AMS in a cardiac surgical intensive care unit (CICU), by determination with the reduction of: inotropic support, length of antibiotic treatment, and need for renal replacement therapy (RRT).</p><p><strong>Material and methods: </strong>The research is a retrospective, group comparative, analytical cross-sectional study, in the period from 2020-2023, within the Cardiosurgery department, at Acibadem Sistina. 1277 patients participated in the research, divided into two groups: group 1 (2020-2021) and group 2 (2022-2023). Primary endpoints investigated: inotropic support, need for RRT and length of antibiotic treatment. Secondary endpoints investigated: optimization of antibiotic therapeutic regimen and clinical outcome assessment of patients (survival).</p><p><strong>Results: </strong>The inotropic support during 24, 48 and 72 h was statistically significantly lower in group 2. A statistically significant shorter length of time for antibiotic treatment was determined in patients in group 2 (p=0.000), as well as a lower value of the need for RRT. A statistically significant difference in time to event (fatal outcome) was determined between the two groups (p=0.000). A significant difference (p=0.000) was determined in the prescription and optimization of the therapeutic regimen.</p><p><strong>Conclusion: </strong>Integrating AMS, initial comprehensive microbiological screening and application of biomarkers in the CICU, established appropriately, will result in improved overall clinical outcome for patients.</p>\",\"PeriodicalId\":74492,\"journal\":{\"name\":\"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)\",\"volume\":\"45 3\",\"pages\":\"13-24\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2478/prilozi-2024-0019\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/1 0:00:00\",\"PubModel\":\"Print\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/prilozi-2024-0019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/1 0:00:00","PubModel":"Print","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:耐药微生物的高流行率表明需要多学科方法,这将确保在重症监护(ICU)中选择耐药治疗和实施抗菌药物管理(AMS)计划之间的效率和平衡。目的:目的是基于心脏外科重症监护病房(CICU) AMS的评估,通过确定:肌力支持的减少、抗生素治疗的长度和肾脏替代治疗(RRT)的需要。材料和方法:该研究是一项回顾性、分组比较、分析的横断面研究,研究期间为2020-2023年,在Acibadem Sistina的心脏外科,1277名患者参与了研究,分为两组:1组(2020-2021)和2组(2022-2023)。研究的主要终点:肌力支持,RRT的需要和抗生素治疗的时间。次要研究终点:优化抗生素治疗方案和患者临床结果评估(生存)。结果:2组患者24、48、72 h的肌力支持均明显降低。2组患者的抗生素治疗时间较短(p=0.000),需要RRT的值较低,具有统计学意义。两组之间发生事件(致命结局)的时间差异有统计学意义(p=0.000)。两组在处方和治疗方案的优化上存在显著差异(p=0.000)。结论:整合AMS,初步全面的微生物学筛选和生物标志物在CICU的应用,适当建立,将改善患者的整体临床结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Implementing an Antimicrobial Stewardship Program and Complete Screening in an Intensive Care Unit in Relation to the Overall Clinical Outcome of Patients.

Background: The high prevalence of resistant microorganisms indicates a multidisciplinary approach, which will ensure efficiency and balance between resistance therapy of choice and the implementation of an antimicrobial stewardship (AMS) program in intensive unit care (ICU).

Objectives: The objectives are based on the assessment of AMS in a cardiac surgical intensive care unit (CICU), by determination with the reduction of: inotropic support, length of antibiotic treatment, and need for renal replacement therapy (RRT).

Material and methods: The research is a retrospective, group comparative, analytical cross-sectional study, in the period from 2020-2023, within the Cardiosurgery department, at Acibadem Sistina. 1277 patients participated in the research, divided into two groups: group 1 (2020-2021) and group 2 (2022-2023). Primary endpoints investigated: inotropic support, need for RRT and length of antibiotic treatment. Secondary endpoints investigated: optimization of antibiotic therapeutic regimen and clinical outcome assessment of patients (survival).

Results: The inotropic support during 24, 48 and 72 h was statistically significantly lower in group 2. A statistically significant shorter length of time for antibiotic treatment was determined in patients in group 2 (p=0.000), as well as a lower value of the need for RRT. A statistically significant difference in time to event (fatal outcome) was determined between the two groups (p=0.000). A significant difference (p=0.000) was determined in the prescription and optimization of the therapeutic regimen.

Conclusion: Integrating AMS, initial comprehensive microbiological screening and application of biomarkers in the CICU, established appropriately, will result in improved overall clinical outcome for patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信